drugset / Trial / NCT00178828

Dynamic Measures of Neurochemistry in Mood Disorders

NCT00178828

Phase 4 Completed 42 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to understand changes in brain chemical signals when people take antidepressants called sertraline (Zoloft®) and bupropion (Wellbutrin SR, Zyban ®). Spinal fluid is used to measure chemical levels of dopamine, serotonin, and other chemicals thought to be involved in depression. The study has potential to help understand and treat depression.

Timeline

Start
2002-10
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 150 mg
Subject Sertraline Small molecule 100 mg

Indications